Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
Subscribe To Our Newsletter & Stay Updated
